TickerFacts.

Company research / AUPH

Aurinia Pharmaceuticals Inc. (AUPH)

Build a valuation ↗↓ Download CSV

CIK 0001600620 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Aurinia Pharmaceuticals Inc. reported revenue of $283.06M. Revenue grew 20.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

37.1%
Operating margin
101.5%
Net margin
49.4%
Return on year-end equity
20.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-25

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue$283.06M$235.13M$175.51M$134.03M$45.60M$50.12M$318.0K$463.0K—
Cost of Revenue$32.66M$28.25M$14.15M$5.66M$1.09M$0$0——
Operating Income$104.91M-$4.69M-$91.69M-$111.47M-$180.74M-$104.29M-$90.94M-$55.24M—
Net Income$287.20M$5.75M-$78.02M-$108.18M-$180.97M-$102.68M-$88.39M-$53.08M—
EPS (Diluted)$2.07$0.04$-0.54$-0.76$-1.40$-0.87$-0.95——
Total Assets$751.59M$550.64M$548.06M$470.86M$543.37M$463.66M$324.30M——
Total Liabilities$170.26M$173.17M$170.11M$65.42M$64.28M$55.91M$25.70M——
Shareholders' Equity$581.33M$377.48M$377.95M$405.44M$479.09M$407.75M$298.60M$135.72M$177.92M
Cash & Equivalents$80.16M$83.40M$48.76M$94.09M$231.64M$272.35M$306.02M——
Operating Cash Flow$135.66M$44.39M-$33.46M-$79.53M-$157.69M-$69.86M-$63.59M-$51.61M—
Shares Outstanding132.32M140.88M143.83M142.27M141.60M126.70M111.80M85.50M—
Weighted Average Diluted Shares138.70M146.19M143.24M141.91M129.37M118.47M———
EPS (Basic)$2.14$0.04$-0.54$-0.76$-1.40$-0.87$-0.95——